Literature DB >> 11750362

Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients.

T Haba1, K Uchida, A Katayama, Y Tominaga, T Sato, I Watanabe, H Inagaki, T Kimata, K Goto, K Morozumi, A Takeda, S Takahara, K Takahashi, S Oshima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11750362     DOI： 10.1016/s0041-1345(01)02351-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Authors:  Miroslav Dostalek; Iain Gardner; Brian M Gurbaxani; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

Review 2.  Basiliximab: a review of its use as induction therapy in renal transplantation.

Authors:  Therese M Chapman; Gillian M Keating
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Immune reactivity of renal transplant recipients receiving interleukin-2 receptor antagonists during the early posttransplant period.

Authors:  Stela Zivčić-Ćosić; Jasna Lisjak; Sanjin Rački; Zlatko Trobonjača
Journal:  Int Urol Nephrol       Date:  2013-03-21       Impact factor: 2.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.